Sec Form 4 Filing - PORTACCI MICHAEL T @ COMMUNITY HEALTH SYSTEMS INC - 2015-02-27

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
PORTACCI MICHAEL T
2. Issuer Name and Ticker or Trading Symbol
COMMUNITY HEALTH SYSTEMS INC [ CYH]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
Division President
(Last) (First) (Middle)
4000 MERIDIAN BOULEVARD
3. Date of Earliest Transaction (MM/DD/YY)
02/27/2015
(Street)
FRANKLIN, TN37067
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/27/2015 M 50,000 A $ 40.41 86,210 D
Common Stock 02/27/2015 S 50,000 D $ 48.5601 ( 1 ) 36,210 D
Common Stock 02/27/2015 F 3,496 D $ 48.52 32,714 D
Common Stock 03/01/2015 M 25,000 A $ 0 57,714 D
Common Stock 03/01/2015 M 3,333 A $ 0 61,047 D
Common Stock 03/01/2015 F 4,895 D $ 48.52 56,152 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (Right to Buy) $ 40.41 02/27/2015 M 50,000 07/25/2008 07/24/2015 Common Stock 50,000 $ 0 0 D
Performance Based Restricted $ 0 03/01/2015 M( 2 ) 25,000 03/01/2015 02/29/2024 Common Stock 25,000 $ 0 0 D
Performance Based Restricted $ 0 03/01/2015 M( 3 ) 3,333 03/01/2015( 3 ) 02/29/2024( 3 ) Common Stock 3,333 $ 0 6,667 D
Performance Based Restricted $ 0 03/01/2015 A 35,000 03/01/2016 02/28/2025 Common Stock 35,000 $ 0 35,000 D
Stock Options (Right to Buy) $ 32.28 02/27/2009 02/26/2018 Common Stock 20,000 20,000 D
Stock Options (Right to Buy) $ 33.9 02/24/2011 02/23/2020 Common Stock 10,000 10,000 D
Stock Options (Right to Buy) $ 37.96 02/23/2012 02/22/2021 Common Stock 10,000 10,000 D
Stock Options (Right to Buy) $ 21.07 02/16/2013 02/15/2022 Common Stock 2,667 2,667 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
PORTACCI MICHAEL T
4000 MERIDIAN BOULEVARD
FRANKLIN, TN37067
Division President
Signatures
Christopher G. Cobb, Attorney in Fact for Micheal T. Portacci 03/02/2015
Signature of Reporting Person Date
Explanation of Responses:
( 1 )The shares were sold in a series of transactions at a weighted average price of $48.5601 per share.
( 2 )The performance objectives governing these shares of Performance Based Restricted Stock have been met, and, accordingly, these shares will now be reported in Table 1 as directly owned shares of Restricted Stock. The restrictions lapse in 1/3 increments on the first, second and third anniversary of the date of grant.
( 3 )Each performance based restricted share r epresents a contingent right to receive one share of CYH common stock. The Company has achieved the cost savings ("synergies") from the Health Management Associates, Inc. ("HMA") merger transaction that were required to be achieved during the first year following the merger transaction, and, accordingly, 1/3 of the performance based restricted shares awarded in conjunction with the completion of the HMA merger transaction will now be reported on Table 1 as directly owned shares. The restrictions on such shares have lapsed. The remaining 2/3 of the performance based restricted shares awarded in conjunction with the completion of the HMA merger transaction will remain subject to the two-year performance target, which may be met in whole or in part in the second year following the grant. There is also a time vesting element to the maximum targets of the award. If the objectives are not met, the shares will be forfeited.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.